StockNews.AI
LCTX
StockNews.AI
167 days

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025

1. Lineage Cell Therapeutics will announce Q4 and 2024 results on March 10, 2025. 2. A conference call will follow the announcement, impacting LCTX's market attention.

2m saved
Insight
Article

FAQ

Why Neutral?

The upcoming financial results may vary, similar to past earnings reports that led to mixed market reactions.

How important is it?

Earnings reports significantly impact stock price movements; hence, the upcoming announcement is noteworthy.

Why Short Term?

Immediate market reactions are expected around the announcement date, similar to past quarterly reports.

Related Companies

LCTXSRNEOTIC
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that it will report its fourth quarter and full year 2024 financial and operating results on Monday, March 10, 2025, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Monday, March 10, 2025, at 4:30 p.m.

Related News